This Funding Opportunity Announcement (FOA) encourages research grant applications directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders.
Funding Number:
PAR-13-048
Office:
DN [2]
Expiration Date:
Friday, January 8, 2016
Release Date:
Tuesday, December 18, 2012
Featured Opportunity:
Yes for DN
Funding Type:
PAR